Cap displayed in your preferred currency (USD)
Industries & Sectors
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| Europe (Primary) | PRIMARYEUR | Univ | 6,455 | 18,930,352 | 0.56% | 0.53% | 10.55% | 0.05% | 8.91% | 3.94% |
| Healthcare | HEALTHCARE | Sector | 588 | 2,058,900 | 1.29% | -2.88% | 8.86% | -9.75% | -5.56% | -14.48% |
| Biopharmaceuticals | BIOPHARMA | SubSec | 192 | 1,572,848 | 1.34% | -3.62% | 7.89% | -11.07% | -7.68% | -17.05% |
| Non-System-Specific Biopharmaceuticals | BIOPHARMANONSYS | Industry | 57 | 29,869 | 1.65% | -3.91% | 8.53% | -8.13% | -5.83% | -23.60% |
| Infectious Disease Biopharmaceuticals | INFECTIOUS | SubInd | 13 | 3,496 | 3.77% | 1.16% | 10.52% | -5.89% | 2.08% | -12.13% |
Show Stocks
Sort: 1Mo %
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| Bavarian Nordic A/S | BAVA:DNKBAVA:DNK | Stock | 1 | 1,953 | 6.19% | 3.23% | 17.52% | -6.10% | -20.40% | 1.35% |
| Europe | IMEU:NLDIMEU:NLD | Benchmark | 6,455 | 18,930,352 | 0.42% | 0.42% | 14.10% | 0.37% | 7.35% | 5.16% |
| Basilea Pharmaceutica AG | BSLN:CHEBSLN:CHE | Stock | 1 | 648 | 0.34% | -1.00% | 11.84% | 10.17% | 1.72% | 9.09% |
| Infectious Disease Biopharmaceuticals | INFECTIOUS | SubInd | 13 | 3,496 | 3.77% | 1.16% | 10.52% | -5.89% | 2.08% | -12.13% |
| Valneva SE | VLA:FRAVLA:FRA | Stock | 1 | 517 | 0.14% | -2.68% | 1.29% | -9.47% | 12.75% | -30.23% |
* Colors indicate performance relative to the benchmark.